Vizient Provides Feedback to Government Agencies on Drug Compounding and Improving Competition for Generics and Biosimilars
Vizient offers insights to FDA and USPTO on actions to increase access to compounded drugs and improve opportunities for new generics and biosimilars.
MoreVizient Data Show 610% Increase in Demand for Dexamethasone after Study Shows Effectiveness for Patients Severely Ill with COVID-19
Vizient shares data showing a 610% increase in demand by its members for dexamethasone in the week since study linking treatment for COVID patients.
MoreVizient Announces Novaplus Enhanced Supply Agreement with Pfizer for Six Essential Medications
Vizient announces an agreement with Pfizer to add six drugs identified as “essential medications” to its Novaplus® Enhanced Supply Program.
MoreVizient, AAMC Expand Benchmarking Capabilities to Community Providers through Clinical Practice Solutions Center
Vizient and AAMC announce the launch of community benchmarking capabilities for physicians within the Clinical Practice Solutions Center (CPSC).
MoreVizient Announces Spot Buy Opportunities for Personal Protective Equipment
Vizient Publishes Pain Management Guide to Improve Care, Curb Estimated $635B in Annual Costs
Vizient publishes a guide for establishing a comprehensive pain management program to help hospitals manage patients suffering from chronic pain.
MoreVizient Essential Medications List Updated with 12 Additional Drugs
Vizient adds 12 drugs to its essential medications list; drugs whose absence would threaten hospitals’ ability to provide timely, quality care.
MoreVizient, Inc. Statement on George Floyd’s Death and Protests in America
The senseless killing of an unarmed black man in Minneapolis and the protests that are occurring in cities across the country affect all of us. No one should stand silently by when there is inequality and injustice.
MoreVizient’s Novaplus Enhanced Supply Program Enabled Access to 676,000 Additional Units of Propofol as COVID-19 Cases Surged
A novel Vizient supply program resulted in the availability of an additional 676,000 units of the sedative propofol, used to intubate COVID patients.
MoreVizient Report Offers Insight into Patient, Family Advisor Opinions on Post-COVID Elective Procedures
Vizient report offers insight into the role of patient and family advisor opinions for hospitals preparing to restart elective surgeries in COVID era.
More